Yes, for many glaucoma patients, an iStent placed during cataract surgery can reduce the number of eye drops needed, and some patients stop drops altogether. The iStent is best suited to adults with mild-to-moderate open-angle glaucoma who are already having cataract surgery. Results vary, and some patients still use drops to stay at target pressure. A glaucoma specialist can tell you whether you are a good candidate.
This article explains how the iStent works, what research shows, and what to expect. It is general information, not personal medical advice, so talk with your eye doctor about what is right for you.
Can an iStent reduce my glaucoma eye drops?
An iStent can help many patients with mild-to-moderate open-angle glaucoma use fewer glaucoma eye drops after cataract surgery, and some stop drops entirely. The stent lowers eye pressure by improving fluid drainage. Results vary by patient, so some people still need drops to keep pressure at target. Your surgeon can estimate what is realistic for your eyes.
That matters because daily drops are hard to keep up. In one study of 201 glaucoma patients, 30.3% reported missing at least 5% of their prescribed doses. A routine with fewer drops can be easier to follow. Our team offers this option as part of glaucoma care at Chicago Cornea Consultants.
How does the iStent work during cataract surgery?
The iStent works during cataract surgery by adding a microscopic stent that helps lower eye pressure. After the surgeon removes the cataract and places your chosen intraocular lens, the stent is inserted in the same operating-room session. Because both steps happen together, patients do not need a separate glaucoma procedure.
Glaucoma is typically caused by an imbalance between the eye's fluid production and the outflow of that fluid, which raises intraocular pressure (the pressure inside the eye). The iStent, also called a trabecular micro-bypass stent, helps fluid drain. It belongs to a group of procedures called minimally invasive glaucoma surgery (MIGS). The American Academy of Ophthalmology notes that most of these surgeries use the same incision the surgeon uses to remove the cataract.
What does the research say about medication use after an iStent?
In the FDA pivotal trial, patients who received an iStent inject during cataract surgery were more likely to reach a meaningful pressure reduction without medication than patients who had cataract surgery alone. At 24 months, 75.8% of iStent eyes met that goal, compared with 61.9% of cataract-surgery-only eyes.
"Meaningful" here means at least a 20% drop in medication-free daytime eye pressure from baseline. The trial randomized 387 eyes to cataract surgery with the iStent inject and 118 to cataract surgery alone (FDA summary, P170043). The table shows the medication results.
| Measure | iStent inject + cataract surgery | Cataract surgery alone | Source |
|---|---|---|---|
| Reached ≥20% medication-free pressure reduction at 24 months | 75.8% (288/380) | 61.9% (73/118) | FDA summary |
| Medication-free at 23 months (among patients who reached that pressure goal) | 84% (243/288) | 67% (49/73) | FDA summary |
| Average medications per eye at two years | 0.4 | 0.8 | Singh et al., 2021 |
| Reduction in average medication burden | 75% | 47% | Singh et al., 2021 |
The 84% and 67% figures describe patients who reached the pressure goal, not every patient in the trial. The two-year medication analysis was written by authors affiliated with the device maker, Glaukos. It also reported no unanticipated adverse events and no cases of endophthalmitis, stent dislocation or migration, or hypotony (Singh et al., 2021).
Who is a good candidate for an iStent?
Good candidates for an iStent are adults with mild-to-moderate open-angle glaucoma who are having cataract surgery. According to the American Academy of Ophthalmology, these combined procedures may help patients stop some medications, though not always all of them. A glaucoma exam at Chicago Cornea Consultants can confirm whether the iStent fits your eyes.
If you have both cataracts and glaucoma, you can often address them in one plan. Read more in our guide, Can I Have a Glaucoma Procedure if I Have Cataracts? Your doctor will weigh your diagnosis, eye pressure, and eye anatomy. We also offer the Kahook Dual Blade Goniotomy, another MIGS option, so your surgeon can match the approach to you.
What can you expect after an iStent procedure?
After an iStent procedure, you can expect follow-up visits to check your eye pressure and decide how your glaucoma drops should change. Some patients reduce drops, some stop them, and some continue a smaller routine. Regular visits with your doctor remain important because they help keep glaucoma under control.
Glaucoma often develops without early symptoms, and optic nerve damage cannot be reversed, so ongoing monitoring protects the vision you have. To understand how glaucoma is managed overall, see What Is Glaucoma and How Is It Treated?
Why consider an iStent with Chicago Cornea Consultants?
Chicago Cornea Consultants has used the iStent, also called the trabecular micro-bypass stent, for a number of years to help lower pressure in glaucoma patients. The practice's board-certified ophthalmologists specialize in diagnosing and treating glaucoma, and the practice has found that a good number of patients reach target pressures and discontinue or decrease their drops.
Care starts with a complete exam: eye pressure, corneal thickness, the drainage angle, and imaging of the optic nerve. From there, your doctor builds a plan around your eyes. Learn more about glaucoma specialists in Chicago and the full range of options we offer.
Frequently Asked Questions
Will I still need my glaucoma drops after an iStent?
Some patients still need drops after an iStent, while others reduce or stop them. In the pivotal trial, iStent eyes averaged 0.4 medications at two years versus 0.8 for cataract surgery alone. Your doctor will review your eye pressure at follow-up visits and tell you which drops to continue.
Is the iStent procedure done at the same time as cataract surgery?
Yes, the iStent is placed during the same operating-room session as cataract surgery. After the surgeon removes the cataract and places your intraocular lens, the stent is inserted to help lower eye pressure. This means glaucoma and cataract care happen together in one visit to the operating room.
Does the iStent work for every type of glaucoma?
No, the iStent is intended for adults with mild-to-moderate open-angle glaucoma who are having cataract surgery. Other types, such as angle-closure glaucoma, call for a different plan. A glaucoma specialist can review your diagnosis, eye pressure, and eye anatomy to recommend the right option for you.
How soon will I know whether I can lower my drops?
Your surgeon decides when to adjust your drops by checking your eye pressure at follow-up visits, and the timeline differs for each patient. [PLACEHOLDER: practice's typical schedule for the first drop adjustment.] Ask your surgeon what to expect for your eyes.
Do I still need regular glaucoma check-ups after an iStent?
Yes, regular glaucoma check-ups remain important after an iStent. Glaucoma often has no early symptoms, and optic nerve damage cannot be reversed, so regular visits help your doctor monitor eye pressure and protect your vision. Your doctor will set a follow-up schedule that fits your eyes.
How do I find out if I'm a candidate for an iStent?
Schedule a glaucoma consultation with a specialist who can evaluate your eyes. A complete exam at Chicago Cornea Consultants includes eye pressure measurement, corneal thickness, evaluation of the drainage angle, and imaging of the optic nerve. Your doctor then explains whether an iStent with cataract surgery fits your needs. Request an appointment.
Next Step: Schedule a Consultation
An iStent placed during cataract surgery may help eligible glaucoma patients use fewer eye drops, with results that vary by person. If you have glaucoma and cataracts, schedule a consultation with Chicago Cornea Consultants to learn whether this option fits your eyes. Learn more about our glaucoma care in Chicago, and talk with your eye doctor about the right plan for you.
Sources
- FDA Summary of Safety and Effectiveness, iStent inject (P170043)
- Singh et al., Clinical Ophthalmology, 2021: Stratified Two-Year Outcomes from the Pivotal Trial of iStent inject
- American Academy of Ophthalmology: Combined Cataract-Glaucoma Surgery and MIGS
- Wolfram et al., J Ocul Pharmacol Ther, 2019: Patient-Reported Nonadherence with Glaucoma Therapy

